Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-05
2007-06-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S303000, C514S314000, C514S318000, C514S326000, C546S117000, C546S118000, C546S168000, C546S194000, C546S208000, C546S210000
Reexamination Certificate
active
11378947
ABSTRACT:
The invention relates to compounds of formula (Ic)processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
REFERENCES:
patent: 5489583 (1996-02-01), Mack et al.
patent: 6034215 (2000-03-01), Semple et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6281227 (2001-08-01), Choi-Sledeski et al.
patent: 41 21 947 (1993-01-01), None
patent: 365992 (1990-05-01), None
patent: 0 483 667 (1992-05-01), None
patent: 1 031 563 (2000-08-01), None
patent: 93/01208 (1993-01-01), None
patent: 98/16523 (1998-04-01), None
patent: 98/25611 (1998-06-01), None
patent: 98/47876 (1998-10-01), None
patent: 99/37304 (1999-07-01), None
patent: 99/62904 (1999-12-01), None
patent: 00/40578 (2000-07-01), None
patent: 00/47563 (2000-08-01), None
patent: 00/55188 (2000-09-01), None
patent: 00/69465 (2000-11-01), None
patent: 01/07436 (2001-02-01), None
patent: 01/39759 (2001-06-01), None
patent: 02/060894 (2002-08-01), None
Mack et al., STN International, HCAPLUS Database, Accession No. 1993:428019, Reg. No. 148134-42-3 (2006).
Watson et al., “Design and Synthesis of Orally Active Pyrrolidin-2-one-Based Factor Xa Inhibitors,” Bioorganic & Medicinal Chemistry Letters, vol. 16, pp. 3784-3788 (2006).
Young et al., Structure- and Property-based Design of Factor Xa Inhibitors: Pyrrolidin-2-ones with Acyclic Alanyl Amides as P4 Motifs, Bioorganic & Medicinal Chemistry Letters, vol. 16, pp. 5953-5957 (2006).
J. Enzyme Inhibition, 1995, 9(1), pp. 73-86.
Chan Chuen
Hamblin Julie Nicole
Kelly Henry Anderson
King Nigel Paul
Mason Andrew McMurtrie
Fox Jennifer L.
SmithKline Beecham Corporation
LandOfFree
Pyrrolidin-2-one derivatives as inhibitors of factor xa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidin-2-one derivatives as inhibitors of factor xa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidin-2-one derivatives as inhibitors of factor xa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3829028